Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

Survey responses indicate that bio/pharma faces tariff-driven rising costs and supply strain, with firms aiming to boost compliance and diversification and seeking stable trade and R&D support.

Following FDA IND clearance for neuropathic pain, the Company is preparing to initiate its U.S. Phase 2a trial in Q4 2025 ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

An update from Piramal Pharma Limited ( ($IN:PPLPHARMA) ) is now available. Piramal Pharma Limited announced the completion of a significant ...

A new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant ...

Unlike traditional pharmaceutical companies that own and market their products, CFAO Healthcare South Africa operates as a ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.

The pharmaceutical industry stands at a critical juncture. To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered technologies is ...